Ignite Creation Date:
2025-12-24 @ 1:35 PM
Ignite Modification Date:
2026-01-09 @ 10:44 AM
Study NCT ID:
NCT04170595
Status:
UNKNOWN
Last Update Posted:
2021-03-03
First Post:
2019-11-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Study of Recombinant Anti-HER2 Humanized Monoclonal Antibody for Injection
Sponsor:
Genor Biopharma Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-03-28
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-12
Completion Date Type:
ESTIMATED
First Submit Date:
2019-11-12
First Submit QC Date:
None
Study First Post Date:
2019-11-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-03-02
Last Update Post Date:
2021-03-03
Last Update Post Date Type:
ACTUAL